TWO SIGMA ADVISERS, LP - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 128 filers reported holding ANTARES PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$2,356,000
-1.0%
574,732
-13.8%
0.01%0.0%
Q4 2021$2,380,000
-44.1%
666,532
-43.0%
0.01%
-45.5%
Q3 2021$4,260,000
-25.5%
1,170,332
-10.7%
0.01%
-26.7%
Q2 2021$5,717,000
+17.4%
1,311,232
+10.7%
0.02%
+15.4%
Q1 2021$4,868,000
-0.4%
1,184,432
-3.3%
0.01%0.0%
Q4 2020$4,886,000
+36.0%
1,224,632
-7.9%
0.01%
+30.0%
Q3 2020$3,592,000
-21.0%
1,330,232
-19.6%
0.01%
-23.1%
Q2 2020$4,547,000
+23.0%
1,653,532
+5.5%
0.01%
-7.1%
Q1 2020$3,698,000
-43.3%
1,566,832
+12.9%
0.01%
-6.7%
Q4 2019$6,523,000
+337.8%
1,387,932
+211.7%
0.02%
+275.0%
Q3 2019$1,490,000
+2.5%
445,332
+0.9%
0.00%0.0%
Q2 2019$1,453,000
+22.2%
441,532
+12.5%
0.00%
+33.3%
Q1 2019$1,189,000
+35.1%
392,532
+21.3%
0.00%
+50.0%
Q4 2018$880,000
+126.8%
323,632
+180.1%
0.00%
+100.0%
Q3 2018$388,000
+725.5%
115,532
+441.6%
0.00%
Q1 2018$47,000
-60.8%
21,332
-64.6%
0.00%
Q4 2017$120,000
-34.1%
60,319
+7.4%
0.00%
-100.0%
Q3 2017$182,000
+180.0%
56,185
+179.5%
0.00%
Q2 2017$65,000
+209.5%
20,100
-1.0%
0.00%
Q2 2016$21,000
+16.7%
20,300
+0.5%
0.00%
Q1 2016$18,00020,2000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 1,820,524$4,697,0003.00%
ARMISTICE CAPITAL, LLC 12,050,000$31,089,0002.03%
Broadfin Capital, LLC 4,623,247$11,928,0001.88%
Healthcare Value Capital, LLC 100,000$258,0000.73%
Healthcare Value Capital, LLC 100,000$258,0000.73%
MYCIO WEALTH PARTNERS, LLC 2,433,500$6,278,0000.65%
PERKINS CAPITAL MANAGEMENT INC 317,500$819,0000.59%
Brown Advisory Securities, LLC 275,000$710,0000.12%
FALCON POINT CAPITAL, LLC 222,501$574,0000.11%
Avenir Corp 291,597$752,0000.09%
View complete list of ANTARES PHARMA INC shareholders